Saturday 17 October 2026 Export CLSDQ’s income statement to Excel — free account

Clearside Biomedical, Inc.

Clearside Biomedical, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $1.7 million, down 79.8% from fiscal 2023. In the quarter to September 2025, revenue fell 80.6%, EPS grew 24.0% and free cash flow grew 8.15%, each against the same quarter a year earlier.

0.25 0.00 0.00%

Follow CLSDQ

Alert me

Market cap: $2.2M
P/E: 0.0×
Fwd P/E: −0.1×
Dividend yield: —
F-score: 3/9
Altman Z: −22.08
Beneish M: −1.63
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Mar '25	Jun '25	Sep '25
ROE Full definition →	+8 more TTM periods Free account	125.45%	91.00%	71.96%	58.59%
Piotroski F-Score Full definition →		4	2	2	2
ROA Full definition →		(116.16%)	(103.03%)	(112.50%)	(127.43%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(174.33%)	(218.51%)	(234.80%)	(307.11%)
Average Days of Receivables Full definition →		111.21	149.14	71.49	29.16
Free Cash Flow per Share Full definition →		(5.22)	(4.60)	(4.28)	(4.15)
Free Cash Flow Full definition →		(25.67)	(23.61)	(22.23)	(21.75)
Capital Expenditures Full definition →		(0.98)	(0.93)	(0.51)	(0.45)
Other line items
Cash ROIC Full definition →		136.32%	73.12%	56.49%	46.12%
Accounts Receivable Turnover Full definition →		4.37	3.11	6.49	6.32
Accounts Payable Turnover Full definition →		0.00	0.37	0.00	0.00
Inventory Turnover Full definition →		—	0.00	—	—
Average Days of Payables Full definition →		0.00	1,158.56	0.00	0.00
Days of Inventory on Hand Full definition →		—	0.00	—	—
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		1,117.19%	463.28%	346.11%	397.24%
Selling, General and Administrative Expense of Revenue Full definition →		709.56%	313.68%	268.99%	380.59%
Share Based Compensation of Revenue Full definition →		271.21%	110.84%	89.92%	99.94%
Operating CF/Net income Full definition →		0.72	0.74	0.78	0.82
Depreciation/Fixed assets Full definition →		(0.03)	(0.02)	0.03	0.09
Capex/Depreciation Full definition →		8.65	16.59	(5.44)	(1.62)
Revenue per Share Full definition →		0.34	0.73	0.80	0.64
Operating CF per Share Full definition →		(5.02)	(4.42)	(4.18)	(4.07)
Capex per Share Full definition →		(0.20)	(0.18)	(0.10)	(0.09)
Capex to Sales Full definition →		0.59	0.25	0.12	0.14

Show all line items

Columns are period end dates

Stockrow Weekly